114.51
0.90 (0.79%)
| Penutupan Terdahulu | 113.61 |
| Buka | 113.68 |
| Jumlah Dagangan | 532,414 |
| Purata Dagangan (3B) | 865,295 |
| Modal Pasaran | 8,187,465,216 |
| Harga / Pendapatan (P/E TTM) | 11.82 |
| Harga / Pendapatan (P/E Ke hadapan) | 8.38 |
| Harga / Jualan (P/S) | 0.630 |
| Harga / Buku (P/B) | 21.63 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | 6.63% |
| Margin Operasi (TTM) | 13.44% |
| EPS Cair (TTM) | 10.08 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 5.00% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | -32.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 742.20% |
| Nisbah Semasa (MRQ) | 1.25 |
| Aliran Tunai Operasi (OCF TTM) | 2.34 B |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.58 B |
| Pulangan Atas Aset (ROA TTM) | 7.04% |
| Pulangan Atas Ekuiti (ROE TTM) | 54.79% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Bercampur | Bercampur |
| Medical Care Facilities (Global) | Bercampur | Bercampur | |
| Stok | DaVita Inc. | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 1.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 1.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -4.0 |
| Purata | -0.38 |
|
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the us, and treats about 250,000 patients globally each year. Government payers dominate us dialysis reimbursement. DaVita receives about two thirds of us sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of the us patients treated, they represent nearly all of the profits generated by DaVita in the us dialysis business. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 49.51% |
| % Dimiliki oleh Institusi | 48.76% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 143.00 (Barclays, 24.88%) | Pegang |
| Median | 138.00 (20.51%) | |
| Rendah | 133.00 (TD Cowen, 16.15%) | Pegang |
| Purata | 138.00 (20.51%) | |
| Jumlah | 2 Pegang | |
| Harga Purata @ Panggilan | 118.90 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| TD Cowen | 03 Nov 2025 | 133.00 (16.15%) | Pegang | 119.05 |
| Barclays | 30 Oct 2025 | 143.00 (24.88%) | Pegang | 118.75 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 21 Jan 2026 | Pengumuman | DaVita Inc. Schedules 4th Quarter 2025 Investor Conference Call |
| 11 Dec 2025 | Pengumuman | DaVita Names New Leaders to Accelerate Care Transformation |
| 14 Nov 2025 | Pengumuman | DaVita Inc. to Participate in Fireside Chat with Wolfe Research |
| 04 Nov 2025 | Pengumuman | DaVita Marks 25 Years of Innovation with Breakthrough Kidney Care Research at ASN Kidney Week 2025 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |